| Product Code: ETC11661966 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India clinical trial imaging services market import shipments witnessed a slight decline with a negative CAGR from 2020 to 2024. The growth rate between 2023 and 2024 showed a more significant decrease, indicating a slowing trend in market expansion during that period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Clinical Trial Imaging Services Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Clinical Trial Imaging Services Market Revenues & Volume, 2021 & 2031F |
3.3 India Clinical Trial Imaging Services Market - Industry Life Cycle |
3.4 India Clinical Trial Imaging Services Market - Porter's Five Forces |
3.5 India Clinical Trial Imaging Services Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.6 India Clinical Trial Imaging Services Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 India Clinical Trial Imaging Services Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.8 India Clinical Trial Imaging Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Clinical Trial Imaging Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for clinical trials in India |
4.2.2 Technological advancements in imaging services |
4.2.3 Rising prevalence of chronic diseases requiring clinical trials |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for conducting clinical trials in India |
4.3.2 High cost associated with clinical trial imaging services |
4.3.3 Limited availability of skilled professionals in the imaging services sector |
5 India Clinical Trial Imaging Services Market Trends |
6 India Clinical Trial Imaging Services Market, By Types |
6.1 India Clinical Trial Imaging Services Market, By Modality |
6.1.1 Overview and Analysis |
6.1.2 India Clinical Trial Imaging Services Market Revenues & Volume, By Modality, 2021 - 2031F |
6.1.3 India Clinical Trial Imaging Services Market Revenues & Volume, By Computed Tomography (CT) Scan, 2021 - 2031F |
6.1.4 India Clinical Trial Imaging Services Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021 - 2031F |
6.1.5 India Clinical Trial Imaging Services Market Revenues & Volume, By Xray, 2021 - 2031F |
6.1.6 India Clinical Trial Imaging Services Market Revenues & Volume, By Ultrasound, 2021 - 2031F |
6.1.7 India Clinical Trial Imaging Services Market Revenues & Volume, By Positron Emission Tomography (PET), 2021 - 2031F |
6.2 India Clinical Trial Imaging Services Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 India Clinical Trial Imaging Services Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 India Clinical Trial Imaging Services Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.2.4 India Clinical Trial Imaging Services Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.2.5 India Clinical Trial Imaging Services Market Revenues & Volume, By Endocrinology, 2021 - 2031F |
6.2.6 India Clinical Trial Imaging Services Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Clinical Trial Imaging Services Market, By Service Type |
6.3.1 Overview and Analysis |
6.3.2 India Clinical Trial Imaging Services Market Revenues & Volume, By Operational Imaging Services, 2021 - 2031F |
6.3.3 India Clinical Trial Imaging Services Market Revenues & Volume, By Read Analysis Services, 2021 - 2031F |
6.3.4 India Clinical Trial Imaging Services Market Revenues & Volume, By Trial Design Consulting Services, 2021 - 2031F |
6.3.5 India Clinical Trial Imaging Services Market Revenues & Volume, By System & Technical Support Services, 2021 - 2031F |
6.4 India Clinical Trial Imaging Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Clinical Trial Imaging Services Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 India Clinical Trial Imaging Services Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
6.4.4 India Clinical Trial Imaging Services Market Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031F |
6.4.5 India Clinical Trial Imaging Services Market Revenues & Volume, By Academic and Government Research Institutes, 2021 - 2031F |
7 India Clinical Trial Imaging Services Market Import-Export Trade Statistics |
7.1 India Clinical Trial Imaging Services Market Export to Major Countries |
7.2 India Clinical Trial Imaging Services Market Imports from Major Countries |
8 India Clinical Trial Imaging Services Market Key Performance Indicators |
8.1 Number of new clinical trials initiated utilizing imaging services |
8.2 Adoption rate of advanced imaging technologies in clinical trials |
8.3 Average turnaround time for imaging data analysis in clinical trials. |
9 India Clinical Trial Imaging Services Market - Opportunity Assessment |
9.1 India Clinical Trial Imaging Services Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.2 India Clinical Trial Imaging Services Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 India Clinical Trial Imaging Services Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.4 India Clinical Trial Imaging Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Clinical Trial Imaging Services Market - Competitive Landscape |
10.1 India Clinical Trial Imaging Services Market Revenue Share, By Companies, 2024 |
10.2 India Clinical Trial Imaging Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here